Institute of Hematology & Blood Diseases Hospital, CAMS: Hospital Profile

Best way to think about it: this is a hematology-focused name to check when the case is leukemia, lymphoma, myeloma, MDS, aplastic anemia, transplant, CAR-T, or another blood disease question. It is not a quick-visit option for unstable patients.

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences. Chinese name: 中国医学科学院血液病医院. Pinyin: Zhongguo Yixue Kexueyuan Xueyebing Yiyuan.

Why it belongs on the shortlist

  • It is publicly known as a hematology and blood-disease specialist institution under the Chinese Academy of Medical Sciences.
  • It may be relevant when the case needs hematology-specific diagnostics, transplant thinking, cellular therapy review, or complex second opinion.
  • For foreign patients, the practical question is whether the hospital can review records before travel and whether the patient is stable enough to move.

Where it may fit

Adult leukemia, lymphoma, myeloma, MDS, aplastic anemia, transplant evaluation, relapse decisions, and complicated blood-disease second opinions may be worth checking. For children, families must verify pediatric acceptance and the exact team.

What to verify before you go

  • Can the team review bone marrow, flow cytometry, cytogenetics, molecular reports, and treatment history before travel?
  • Is the patient stable enough to travel?
  • Will treatment require long inpatient stay, isolation, transfusion support, or infection monitoring?
  • Who handles follow-up after leaving China?

Sources to check

Use this as a shortlist, not a diagnosis. Hospitals change doctors, departments, appointment rules, international-patient services, and pricing routes. Before you travel, verify the exact department, doctor or team, documents needed, estimated timeline, cost route, and follow-up plan.

Medical disclaimer: This page is practical orientation, not medical advice, diagnosis, treatment advice, legal advice, or insurance advice.